Landos Biopharma
Why Robinhood?
You can watch LABP and buy or sell other stocks, ETFs, and their options commission-free!About LABP
Landos Biopharma, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of novel, oral, once-daily therapeutics for patients with certain immunology diseases. It offers NX-13, a novel, oral, gut-restricted compound for the treatment of inflammatory bowel disease, which targets the NLRX1 pathway.
LABP Key Statistics
Stock Snapshot
Landos Biopharma(LABP) stock is priced at $3.39, giving the company a market capitalization of 71.47M. It carries a P/E multiple of -5.74.
Landos Biopharma(LABP) stock opened on 2026-03-12 at —. The price climbed to — and dipped to —.
Landos Biopharma(LABP) shares are trading with a volume of 0.
In the last year, Landos Biopharma(LABP) shares hit a 52-week high of $22.94 and a 52-week low of $21.90.
In the last year, Landos Biopharma(LABP) shares hit a 52-week high of $22.94 and a 52-week low of $21.90.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.